Conjupro Biotherapeutics Inc. — Form D

Conjupro Biotherapeutics Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-12. The offering totals $67.5M, of which $9.3M was reported sold. Industry: Other.

Offering

• Filed: 2023-09-12
• Form: D
• Accession: 0001993155-23-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $67.5M
• Amount sold: $9.3M
• Remaining: $58.1M
• Investors: 1
• Date of first sale: 2023-09-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-491870

Issuer

• Name: Conjupro Biotherapeutics Inc.
• CIK: 0001993155
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 302 CARNEGIE CENTER BLVD, SUITE 100, PRINCETON, NJ, 08540
• Phone: 609-356-0210

Officers, directors & promoters (3)

More

• CIK 1993155 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search